Ethnic delineation of primary glioblastoma genome
暂无分享,去创建一个
In-Hee Lee | H. Seol | Jung-Il Lee | D. Kong | D. Nam | H. Cho | S. Choi | Harim Koo | J. Choi | J. Sa
[1] T. Rebbeck,et al. Integrated Analysis of Genetic Ancestry and Genomic Alterations across Cancers. , 2018, Cancer cell.
[2] Edward F. Chang,et al. Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment. , 2017, Cancer cell.
[3] Steven J. M. Jones,et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma , 2016, Cell.
[4] In-Hee Lee,et al. Spatiotemporal Evolution of the Primary Glioblastoma Genome. , 2015, Cancer cell.
[5] Steven J. M. Jones,et al. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. , 2015, The New England journal of medicine.
[6] Jill S. Barnholtz-Sloan,et al. Epidemiologic and Molecular Prognostic Review of Glioblastoma , 2014, Cancer Epidemiology, Biomarkers & Prevention.
[7] T. Cloughesy,et al. Glioblastoma: from molecular pathology to targeted treatment. , 2014, Annual review of pathology.
[8] David T. W. Jones,et al. Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge , 2014, Nature Reviews Cancer.
[9] D. Haussler,et al. The Somatic Genomic Landscape of Glioblastoma , 2013, Cell.
[10] Raul Rabadan,et al. The integrated landscape of driver genomic alterations in glioblastoma , 2013, Nature Genetics.
[11] A. Sivachenko,et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.
[12] D. Brat,et al. Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma , 2012, Science.
[13] Paul S Mischel,et al. Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors. , 2012, Cancer discovery.
[14] Lynda Chin,et al. Emerging insights into the molecular and cellular basis of glioblastoma. , 2012, Genes & development.
[15] Debyani Chakravarty,et al. Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response , 2012, Proceedings of the National Academy of Sciences.
[16] C. Brennan,et al. Molecular subclassification of diffuse gliomas: Seeing order in the chaos , 2011, Glia.
[17] G. Riggins,et al. Molecular targeting of glioblastoma: Drug discovery and therapies. , 2011, Trends in molecular medicine.
[18] F. Collins,et al. The path to personalized medicine. , 2010, The New England journal of medicine.
[19] R. Wilson,et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. , 2010, Cancer cell.
[20] Derek Y. Chiang,et al. The landscape of somatic copy-number alteration across human cancers , 2010, Nature.
[21] S. Gabriel,et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.
[22] R. McLendon,et al. IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.
[23] Andrey Korshunov,et al. Analysis of the IDH1 codon 132 mutation in brain tumors , 2008, Acta Neuropathologica.
[24] Joshua M. Korn,et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.
[25] B. Scheithauer,et al. The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.
[26] P. Kleihues,et al. Genetic pathways to primary and secondary glioblastoma. , 2007, The American journal of pathology.
[27] Thomas D. Wu,et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.
[28] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[29] Jill S Barnholtz-Sloan,et al. CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014 , 2017, Neuro-oncology.
[30] R. Barnard,et al. The classification of tumours of the central nervous system. , 1982, Neuropathology and applied neurobiology.